国产综合精品一区二区,国产精品久久国产三级国电话系列,久久精品国产亚洲a不卡,国产精品第7页,最新欧美精品一区二区三区,国产一区二区久久,国产三级一区二区三区

資訊|論壇|病例

搜索

首頁 醫(yī)學論壇 專業(yè)文章 醫(yī)學進展 簽約作者 病例中心 快問診所 愛醫(yī)培訓 醫(yī)學考試 在線題庫 醫(yī)學會議

您所在的位置:首頁 > 肝病科診療指南 > 2012肝癌臨床實踐指南

2012肝癌臨床實踐指南

2014-06-06 15:22 閱讀:6338 來源:愛愛醫(yī) 責任編輯:張子玲
[導讀] Hepatobiliary cancers are highly lethal cancers including a spectrum ofinvasive carcinomas arising in the liver (hepatocellular carcinoma;HCC), bile ducts (intrahepatic and extrahepatic cholangiocarcinoma)and gall bladder.

    《2012肝癌臨床實踐指南》內容簡介:

    Hepatobiliary cancers are highly lethal cancers including a spectrum ofinvasive carcinomas arising in the liver (hepatocellular carcinoma;HCC), bile ducts (intrahepatic and extrahepatic cholangiocarcinoma)and gall bladder. Cholangiocarcinomas and gallbladder cancer arecollectively known as biliary tract cancers. In the United States, anestimated 26,190 and 9,250 cases will be diagnosed with liver orintrahepatic bile duct cancer and gallbladder cancer or other biliary tractcancer, respectively in 2011 with approximately 19,590 deaths fromliver or intrahepatic bile duct cancer, and 3,300 deaths due togallbladder cancer or other biliary tract cancer occurring during thatyear.

    《2012肝癌臨床實踐指南》內容預覽:

    For patients with an incidental liver mass or nodule found onultrasound, the guidelines recommend evaluation using one or more ofthe imaging modalities (at least a 3-phase contrast-enhanced CT orMRI including the arterial and portal venous phase) to determine theperfusion characteristics, extent and the number of lesions, vascularanatomy and extrahepatic disease. The number and type of imaging isdependent on the size of the liver mass or nodule.

    Liver lesions less than 1 cm should be evaluated by at least a 3-phasecontrast-enhanced CT or MRI or CEUS every 3-6 months, withenlarging lesions evaluated according to size. Patients with lesionsstable in size should be followed with imaging every 3-6 months usingthe same imaging modality that was first used to identify the nodules.

    點擊下載***:《2012肝癌臨床實踐指南》


分享到:
  版權聲明:

  本站所注明來源為"愛愛醫(yī)"的文章,版權歸作者與本站共同所有,非經授權不得轉載。

  本站所有轉載文章系出于傳遞更多信息之目的,且明確注明來源和作者,不希望被轉載的媒體或個人可與我們

  聯(lián)系zlzs@120.net,我們將立即進行刪除處理

意見反饋 關于我們 隱私保護 版權聲明 友情鏈接 聯(lián)系我們

Copyright 2002-2026 Iiyi.Com All Rights Reserved